These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17851700)

  • 1. Intermittent or daily administration of 1-alpha calcidol for nephrectomised infants on peritoneal dialysis?
    Saarinen TT; Arikoski P; Holmberg C; Rönnholm K
    Pediatr Nephrol; 2007 Nov; 22(11):1931-8. PubMed ID: 17851700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphacalcidol oral pulses are effective in secondary hyperparathyroidism prior to dialysis.
    Koskimies O; Ala-Houhala M
    Clin Nephrol; 1996 Jul; 46(1):70-1. PubMed ID: 8832157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of metabolic bone disease in the pre-end-stage renal disease setting.
    Coburn JW; Elangovan L
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S71-7. PubMed ID: 11443772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term effects of a combination of 25-hydroxycholecalciferol and 1-alpha-hydroxycholecalciferol on osteodystrophy in chronic hemodialysis patients].
    Sebert JL; Marie A; Kuntz D; Marie P; Gueris J; Smadja A; Fournier A; Quichaud J
    Rev Rhum Mal Osteoartic; 1981; 48(7-9):535-41. PubMed ID: 7291931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India.
    Sankarasubbaiyan S; Abraham G; Soundararajan P; Chandrasekaran V; Padma G
    Hemodial Int; 2005 Jan; 9(1):63-7. PubMed ID: 16191055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of reduced bone density with ibandronate in dialysis patients.
    Bergner R; Henrich D; Hoffmann M; Schmidt-Gayk H; Lenz T; Upperkamp M
    J Nephrol; 2008; 21(4):510-6. PubMed ID: 18651540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar predictive value of bone turnover using first- and second-generation immunometric PTH assays in pediatric patients treated with peritoneal dialysis.
    Salusky IB; Goodman WG; Kuizon BD; Lavigne JR; Zahranik RJ; Gales B; Wang HJ; Elashoff RM; Jüppner H
    Kidney Int; 2003 May; 63(5):1801-8. PubMed ID: 12675856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients.
    Dogan E; Erkoc R; Sayarlioglu H; Soyoral Y; Dulger H
    Ren Fail; 2008; 30(4):407-10. PubMed ID: 18569914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse oral versus pulse intraperitoneal calcitriol: a comparison of efficacy in the treatment of hyperparathyroidism and renal osteodystrophy in peritoneal dialysis patients.
    Gadallah MF; Arora N; Torres C; Ramdeen G; Schaeffer-Pautz A; Moles K
    Adv Perit Dial; 2000; 16():303-7. PubMed ID: 11045316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D therapy in children on dialysis.
    Wesseling K; Salusky IB
    Perit Dial Int; 2007; 27(6):651-3. PubMed ID: 17984426
    [No Abstract]   [Full Text] [Related]  

  • 12. Catch-up growth with normal parathyroid hormone levels in chronic renal failure.
    Waller S; Ledermann S; Trompeter R; van't Hoff W; Ridout D; Rees L
    Pediatr Nephrol; 2003 Dec; 18(12):1236-41. PubMed ID: 14586680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous alfacalcidol once weekly pulse therapy for secondary hyperparathyroidism in hemodialysis patients.
    El-Shafey EM; Alsahow AE; El-Nagar GF; Ezzat A
    Ren Fail; 2011; 33(3):329-33. PubMed ID: 21401359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal osteodystrophy (3); its treatment in dialysis patients].
    Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
    Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure.
    Lind L; Lithell H; Wengle B; Wrege U; Ljunghall S
    Scand J Urol Nephrol; 1988; 22(3):219-22. PubMed ID: 3187441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of parathyroid function in patients with a short history of hemodialysis.
    Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
    Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are new vitamin D analogues in renal bone disease superior to calcitriol?
    Salusky IB
    Pediatr Nephrol; 2005 Mar; 20(3):393-8. PubMed ID: 15690188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
    Alghareeb A; Sabry A; Bawadekji H; Alsaran K
    Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of renal osteodystrophy in peritoneal dialysis.
    Weinreich T
    Kidney Int; 1998 Dec; 54(6):2226-33. PubMed ID: 9853289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.